What data powers the Rallies AI report for MRT?

Rallies AI research for MRT combines live market data, financials, news, analyst context, hedge fund ownership, politician disclosures, insider activity, and risk factors.

Is MRT research on Rallies investment advice?

No. Rallies provides research, data, and educational context for MRT. It does not provide personalized investment advice.

MRT (Marti Technologies, Inc.) Stock Analysis - AI Report

Marti Technologies, Inc. (MRT) is a publicly traded Technology sector company. As of May 21, 2026, MRT trades at $2.00 with a market cap of $172.68M and a P/E ratio of 0.00. MRT moved +0.50% today. Year to date, MRT is -13.42%; over the trailing twelve months it is -32.20%. Its 52-week range spans $1.76 to $3.89. Analyst consensus is buy with an average price target of $3.08. Rallies surfaces MRT's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

What is the AI research view on MRT?

Rallies AI research for MRT combines live market data, fundamentals, news, analyst context, hedge fund holdings, politician trades, insider activity, and risk factors into a ticker-specific research workflow.

MRT Key Metrics

Key financial metrics for MRT
Metric	Value
Price	$2.00
Market Cap	$172.68M
P/E Ratio	0.00
EPS	$0.00
Dividend Yield	0.21%
52-Week High	$3.89
52-Week Low	$1.76
Volume	4.94K
Avg Volume	0
Revenue (TTM)	$57.23M
Net Income	$5.46M
Gross Margin	0.00%

Latest MRT News

Marti Technologies Grows FY2025 Revenue 110% to $39.2M, Adjusted EBITDA Loss Narrows — Apr 13, 2026
MRT-8102 Phase 1 Study Shows 85% hsCRP Drop, 94% Achieve <2 mg/L — Jan 8, 2026
Monte Rosa Therapeutics Unveils Interim Phase 1 MRT-8102 CRP Cohort Data Jan. 7 — Jan 6, 2026

Recent MRT Insider Trades

BlueMountain Capital Management, LLC sold 30.00K (~$345.60K) on Jan 31, 2019.
BlueMountain Capital Management, LLC sold 20.00K (~$231.00K) on Jan 31, 2019.
BlueMountain Capital Management, LLC sold 25.26K (~$289.24K) on Jan 31, 2019.

MRT Analyst Consensus

2 analysts cover MRT: 0 strong buy, 1 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $3.08.

Common questions about MRT

What is the AI research view on MRT?: Rallies AI research for MRT combines live market data, fundamentals, news, analyst context, hedge fund holdings, politician trades, insider activity, and risk factors into a ticker-specific research workflow.
What data powers the Rallies AI report for MRT?: Rallies AI research for MRT combines live market data, financials, news, analyst context, hedge fund ownership, politician disclosures, insider activity, and risk factors.
Is MRT research on Rallies investment advice?: No. Rallies provides research, data, and educational context for MRT. It does not provide personalized investment advice.